NCT00464815View on ClinicalTrials.gov

Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

1,025

Participants

Timeline

Start Date

May 2, 2007

Primary Completion Date

April 16, 2008

Study Completion Date

September 10, 2008

Conditions
Infections, Meningococcal
Interventions
BIOLOGICAL

Meningococcal vaccine GSK134612

One intramuscular dose

BIOLOGICAL

Mencevax™ ACWY

One subcutaneous dose

Trial Locations (7)

100

GSK Investigational Site, Taipei

333

GSK Investigational Site, Tao Yuan County

1781

GSK Investigational Site, City of Muntinlupa

110002

GSK Investigational Site, New Delhi

403202

GSK Investigational Site, Goa

452001

GSK Investigational Site, Indore

411 011

GSK Investigational Site, Pune

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY